BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31290765)

  • 1. Targeting the Hedgehog Pathway Using Itraconazole to Prevent Progression of Barrett's Esophagus to Invasive Esophageal Adenocarcinoma.
    Kelly RJ; Ansari AM; Miyashita T; Zahurak M; Lay F; Ahmed AK; Born LJ; Pezhouh MK; Salimian KJ; Ng C; Matsangos AE; Stricker-Krongrad AH; Mukaisho KI; Marti GP; Chung CH; Canto MI; Rudek MA; Meltzer SJ; Harmon JW
    Ann Surg; 2021 Jun; 273(6):e206-e213. PubMed ID: 31290765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia.
    Wang DH; Clemons NJ; Miyashita T; Dupuy AJ; Zhang W; Szczepny A; Corcoran-Schwartz IM; Wilburn DL; Montgomery EA; Wang JS; Jenkins NA; Copeland NA; Harmon JW; Phillips WA; Watkins DN
    Gastroenterology; 2010 May; 138(5):1810-22. PubMed ID: 20138038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hedgehog signaling regulates FOXA2 in esophageal embryogenesis and Barrett's metaplasia.
    Wang DH; Tiwari A; Kim ME; Clemons NJ; Regmi NL; Hodges WA; Berman DM; Montgomery EA; Watkins DN; Zhang X; Zhang Q; Jie C; Spechler SJ; Souza RF
    J Clin Invest; 2014 Sep; 124(9):3767-80. PubMed ID: 25083987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From Reflux Esophagitis to Esophageal Adenocarcinoma.
    Souza RF
    Dig Dis; 2016; 34(5):483-90. PubMed ID: 27331918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.
    Yen CJ; Izzo JG; Lee DF; Guha S; Wei Y; Wu TT; Chen CT; Kuo HP; Hsu JM; Sun HL; Chou CK; Buttar NS; Wang KK; Huang P; Ajani J; Hung MC
    Cancer Res; 2008 Apr; 68(8):2632-40. PubMed ID: 18413730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of Barrett esophagus and esophageal adenocarcinoma by smoothened inhibitor in a rat model of gastroesophageal reflux disease.
    Gibson MK; Zaidi AH; Davison JM; Sanz AF; Hough B; Komatsu Y; Kosovec JE; Bhatt A; Malhotra U; Foxwell T; Rotoloni CL; Hoppo T; Jobe BA
    Ann Surg; 2013 Jul; 258(1):82-8. PubMed ID: 23108119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastroesophageal reflux and Barrett's esophagus: a pathway to esophageal adenocarcinoma.
    Schlottmann F; Molena D; Patti MG
    Updates Surg; 2018 Sep; 70(3):339-342. PubMed ID: 30039277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to TNF-α Is Increasing Along with the Progression in Barrett's Esophagus.
    Chemnitzer O; Götzel K; Maurer L; Dietrich A; Eichfeld U; Lyros O; Jansen-Winkeln B; Hoffmeister A; Gockel I; Thieme R
    Dig Dis Sci; 2017 Dec; 62(12):3391-3401. PubMed ID: 29086334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High yield reproducible rat model recapitulating human Barrett's carcinogenesis.
    Matsui D; Omstead AN; Kosovec JE; Komatsu Y; Lloyd EJ; Raphael H; Kelly RJ; Zaidi AH; Jobe BA
    World J Gastroenterol; 2017 Sep; 23(33):6077-6087. PubMed ID: 28970723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
    Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen.
    Goldstein SR; Yang GY; Curtis SK; Reuhl KR; Liu BC; Mirvish SS; Newmark HL; Yang CS
    Carcinogenesis; 1997 Nov; 18(11):2265-70. PubMed ID: 9395230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil-Lymphocyte Ratio as a Marker of Progression from Non-Dysplastic Barrett's Esophagus to Esophageal Adenocarcinoma: a Cross-Sectional Retrospective Study.
    Campos VJ; Mazzini GS; Juchem JF; Gurski RR
    J Gastrointest Surg; 2020 Jan; 24(1):8-18. PubMed ID: 31745889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial Endoscopic Evaluation of Esophageal Disease in a Cancer Model: A Paradigm Shift for Esophageal Adenocarcinoma (EAC) Drug Discovery and Development.
    Omstead AN; Kosovec JE; Matsui D; Martin SA; Smith MA; Aaron Guel D; Kolano J; Komatsu Y; Habib F; Lai C; Christopher K; Kelly RJ; Zaidi AH; Jobe BA
    Cancer Invest; 2018; 36(7):363-370. PubMed ID: 30142016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Barrett's metaplasia the source of adenocarcinomas of the cardia?
    Clark GW; Smyrk TC; Burdiles P; Hoeft SF; Peters JH; Kiyabu M; Hinder RA; Bremner CG; DeMeester TR
    Arch Surg; 1994 Jun; 129(6):609-14. PubMed ID: 8204035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From reflux esophagitis to Barrett's esophagus and esophageal adenocarcinoma.
    Wang RH
    World J Gastroenterol; 2015 May; 21(17):5210-9. PubMed ID: 25954094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell kinetic study on histogenesis of Barrett's esophagus using rat reflux model.
    Kumagai H; Mukaisho K; Sugihara H; Bamba M; Miyashita T; Miwa K; Hattori T
    Scand J Gastroenterol; 2003 Jul; 38(7):687-92. PubMed ID: 12889552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survivin, a potential biomarker in the development of Barrett's adenocarcinoma.
    Vallböhmer D; Peters JH; Oh D; Kuramochi H; Shimizu D; Demeester SR; Hagen JA; Chandrasoma PT; Danenberg KD; DeMeester TR; Danenberg P
    Surgery; 2005 Oct; 138(4):701-6; discussion 706-7. PubMed ID: 16269299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence.
    Mokrowiecka A; Veits L; Falkeis C; Musial J; Kordek R; Lochowski M; Kozak J; Wierzchniewska-Lawska A; Vieth M; Malecka-Panas E
    Pathol Res Pract; 2017 Mar; 213(3):205-209. PubMed ID: 28216140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the BMP pathway prevents development of Barrett's-associated adenocarcinoma in a surgical rat model.
    Westra WM; Straub D; Milano F; Buttar NS; Wang KK; Krishnadath KK
    Dis Esophagus; 2022 May; 35(5):. PubMed ID: 34718471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotype of columnar-lined esophagus in rats with esophagogastroduodenal anastomosis: similarity to human Barrett's esophagus.
    Su Y; Chen X; Klein M; Fang M; Wang S; Yang CS; Goyal RK
    Lab Invest; 2004 Jun; 84(6):753-65. PubMed ID: 15094711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.